Balaxi Pharmaceuticals logo

Balaxi Pharmaceuticals

BALAXI NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹128 Cr
Volatility
Moderate
P/E Ratio
51.98
EBITDA
₹8.52 Cr
Return on Equity
10.82%
Debt to Equity
0.23
Book Value
₹45.12
52W High
₹47.71
52W Low
₹15.2

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Stock is trading at 0.52 times its book value

Weaknesses

7
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 3.15% over past five years.
  • Company has a low return on equity of -3.58% over last 3 years.
  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.3.62 Cr.
  • Company has high debtors of 184 days.
  • Promoter holding has decreased over last 3 years: -5.23%

Growth Rate

Revenue Growth
-8.39% lower than 3Y
Net Income Growth
-92.63% lower than 3Y
Cash Flow Change
-819% lower than 3Y
ROE
—
ROCE
582% higher than 3Y
EBITDA Margin (Avg.)
-72.54% higher than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
65.96
54.72
60.79
59.83
65.62
77.38
73.29
76.27
70.74
56.18
72.54
70.71
80.68
Expenses
57.12
43.96
47.14
46.36
55.53
66.79
69.3
63.72
66.58
55.02
69.45
70.59
76.02
Operating Profit
8.84
10.76
13.65
13.47
10.09
10.59
3.99
12.55
4.16
1.16
3.09
0.12
4.66
OPM %
13.4%
19.66%
22.45%
22.51%
15.38%
13.69%
5.44%
16.45%
5.88%
2.06%
4.26%
0.17%
5.78%
Other Income
-47.68
5.93
1.51
-0.7
-1.85
-4.11
3.94
-1.69
-1.78
1.59
0.1
2.92
-0.99
Interest
0.29
0.37
0.41
0.61
0.37
0.45
1.38
0.74
1.01
0.89
1.02
0.99
0.73
Depreciation
0.29
0.66
0.48
0.67
0.49
0.46
0.48
0.46
0.46
0.48
0.56
0.65
0.85
PBT
-39.42
15.66
14.27
11.49
7.38
5.57
6.07
9.66
0.91
1.38
1.61
1.4
2.09
Tax %
4.9%
7.92%
4.77%
4.87%
12.06%
17.41%
11.7%
10.56%
67.03%
84.06%
80.75%
56.43%
38.28%
Net Profit
-41.34
14.43
13.59
10.93
6.48
4.59
5.36
8.64
0.29
0.21
0.31
0.61
1.3
EPS in Rs
-8.07
2.82
2.65
2.01
1.17
0.83
0.97
1.57
0.05
0.04
0.06
0.11
0.24
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
14
46
231
279
336
241
293
270
280
Expenses
12
37
189
229
279
197
260
262
271
Operating Profit
2
8
43
51
57
45
32
9
9
OPM %
11%
18%
18%
18%
17%
18%
11%
3.2%
3.2%
Other Income
1
1
2
5
3
-38
2
3
4
Interest
0
0
0
1
1
3
4
4
4
Depreciation
0
0
0
1
2
2
2
2
3
PBT
2
9
44
55
57
2
29
5
6
Tax %
19%
31%
14%
13%
19%
219%
13%
73%
—
Net Profit
2
6
38
48
46
-2
25
1
2
EPS in Rs
1.3
1.22
7.63
9.53
9.03
-0.44
4.54
0.26
0.45
Div. Payout %
0%
0%
0%
1%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
3
10
10
10
10
11
11
11
Reserves
0
18
55
103
173
190
221
238
Borrowings
0
0
4
4
13
19
53
58
Other Liabilities
3
8
31
60
43
38
25
30
Total Liabilities
6
36
100
176
240
258
310
337
Fixed Assets
0
0
2
29
41
41
41
82
CWIP
0
0
0
1
3
2
22
0
Investments
0
0
3
0
0
0
0
0
Other Assets
6
36
94
147
195
215
247
255
Total Assets
6
36
100
176
240
258
310
337
Figures in ₹ Crores

Cash Flow

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-2
-14
0
34
6
5
-35
-4
Investing
0
0
-6
-28
-11
-1
-22
-21
Financing
0
18
4
0
26
30
34
0
Net Cash Flow
-2
4
-2
6
21
34
-23
-25
Free Cash Flow
-2
-14
-3
7
-9
4
-57
-25
CFO/OP
-97
-161
6
78
32
26
-98
3
Figures in ₹ Crores

Ratios

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
147
238
121
36
57
84
138
184
Inventory Days
—
9
29
184
189
233
173
202
Days Payable
—
64
53
92
62
82
36
51
Cash Conversion Cycle
147
183
97
129
184
235
275
335
Working Capital Days
82
181
91
92
122
142
186
236
ROCE %
—
57%
93%
60%
37%
21%
13%
3%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Balaxi Pharmaceuticals insights

57 extracted metrics + investor summaries across FY19–FY27.

Log in — free

Shareholding Pattern

DIIs2.56%Promot.65.99%Others7.02%Public24.43%As ofJun 2026

Documents

Frequently Asked Questions about Balaxi Pharmaceuticals

What does Balaxi Pharmaceuticals Ltd do?
Balaxi Pharmaceuticals Ltd is an IPR-based pharmaceutical Company engaged in producing, stocking, selling, and supplying branded and generic medicines. [1]
Where is Balaxi Pharmaceuticals Ltd (BALAXI) listed?
Balaxi Pharmaceuticals Ltd trades as BALAXI on the NSE.
Which sector does Balaxi Pharmaceuticals Ltd belong to?
Balaxi Pharmaceuticals Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Balaxi Pharmaceuticals Ltd?
Balaxi Pharmaceuticals Ltd has a market capitalisation of ₹127.64 Cr, which places it in the Small Cap band.
What is the PE ratio of Balaxi Pharmaceuticals Ltd?
Balaxi Pharmaceuticals Ltd trades at a PE ratio of 51.98, against a book value of ₹45.12 per share.
What is the 52-week high and low of Balaxi Pharmaceuticals Ltd?
Over the last 52 weeks Balaxi Pharmaceuticals Ltd has traded between ₹15.2 and ₹47.71.
Does Balaxi Pharmaceuticals Ltd pay dividends?
Balaxi Pharmaceuticals Ltd has a dividend yield of 2.15%.
What is the Return on Equity (ROE) of Balaxi Pharmaceuticals Ltd?
Balaxi Pharmaceuticals Ltd reported a return on equity of 10.82%. Its debt-to-equity ratio is 0.23.

Company Information

Balaxi Pharmaceuticals Ltd is an IPR-based pharmaceutical Company engaged in producing, stocking, selling, and supplying branded and generic medicines. [1]

Website balaxiventures.in
Listed 2015-11-30
Face Value ₹ 2
Issued Size 5,52,07,500

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/BALAXI.md for Balaxi Pharmaceuticals Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List